A family of institutions
working together on the Can Ruti Campus
CEEISCAT and the Grupo de Trabajo sobre Tratamientos del VIH (gTt-VIH) announce the start of data collection for the SEXPROM Study, a pioneering investigation in Spain that will explore sexual satisfaction among people living with HIV, with a differentiated focus by gender and sexual orientation.
The combination of the drug nivolumab with chemotherapy improves survival in patients with high-risk head and neck cancer and could become the new standard treatment, according to the results of an international trial led by professionals from ICO, IGTP and IDIBELL.
The IGTP is accredited as Instituto de Investigación Sanitaria (IIS) by the Instituto de Salud Carlos III (Spanish Government)
The IGTP is a member of
Governance
With the support of
Accreditation
